Shubhra Jain

Shubhra Jain, MD, MBA, currently serves as the Head of Healthcare Investments at Tarsadia Investments, where responsibilities include leading venture and growth investments in health and bio, overseeing a select portfolio that includes Fathom, Phil, Cue, and Chronus. Additionally, Shubhra holds the position of Managing Partner at a Stealth Mode company and has been an Investor for Berkeley Lights, Inc. and Zymergen since 2018. As a Global Mentor for Endeavor, Shubhra supports high-impact entrepreneurs, while also advising and mentoring digital health startups as part of the Springboard Enterprises Digital Health Council. Involvement includes serving as a Board Member for FemTech Collective and holding board positions at Mission Bio and Bioniz Therapeutics Inc. Shubhra’s academic credentials include multiple MBA degrees from The Wharton School and INSEAD, as well as a Master's in Mechanical Engineering from Stanford University and an MBBS from Kasturba Medical College, Manipal.